📄 medicine

An Artificial Intelligence-Informed review of the Antioxidant and Anticancer Properties of Onion (Allium cepa) and Tomato (Solanum lycopersicum) in Prostate Cancer Prevention and Management: A Contemporary Review

This contemporary review synthesizes evidence on the antioxidant and anticancer properties of onion and tomato phytochemicals in prostate cancer prevention, highlighting their mechanisms against oxidative stress and inflammation while demonstrating how artificial intelligence tools like molecular docking and machine learning can prioritize bioactive compounds and address translational challenges such as bioavailability and clinical efficacy.

Original authors: A. O. Alli

Published 2026-07-14

📖 6 min read🧠 Deep dive

CC BY 4.0

Original authors: A. O. Alli

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ✨ This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer

Imagine your body as a bustling city. Sometimes, tiny troublemakers called Reactive Oxygen Species (ROS) start a riot, damaging the city's buildings (your DNA) and causing chaos. In men, this chaos can sometimes turn a specific neighborhood—the prostate—into a dangerous zone where cancer cells grow out of control. This is Prostate Cancer, a serious problem that affects about 1.4 million men every year and kills 375,000.

Currently, doctors have weapons to fight this, like chemical therapies and radiation. But the enemy is tricky; it often builds shields (resistance) or the weapons hurt the city too much (toxicity). So, scientists are looking for a different kind of defense: superfoods. Specifically, this paper investigates two kitchen heroes: Onions (Allium cepa) and Tomatoes (Solanum lycopersicum).

The Superheroes: Quercetin and Lycopene

Think of onions and tomatoes as two different types of security guards, each with a unique superpower.

1. The Onion Guard (Quercetin)
Onions are packed with a compound called quercetin. The paper suggests that quercetin acts like a clever mechanic in the city's power plant. Inside your cells, there's a "sensor" called Keap1 that usually keeps a helpful repair crew (Nrf2) locked up. When troublemakers (oxidative stress) attack, quercetin sneaks in and pokes the sensor (modifying it), which unlocks the repair crew. This crew then builds shields to stop the damage.

The Cool Part: In computer simulations (not real-life human tests yet), quercetin was shown to grab onto a specific protein called the Androgen Receptor (which fuels some prostate cancers) even tighter than a famous drug called enzalutamide. It's like finding a key that fits a lock better than the master key the doctors usually use.
The Catch: The paper is very clear that while this looks amazing in a computer, we don't know for sure if it works perfectly in a human body yet. Also, onions have a "secret weapon" in their skins! Onion peel extracts are 2.3 times more powerful at fighting free radicals than the onion flesh itself, yet we usually throw the skins away.

2. The Tomato Guard (Lycopene)
Tomatoes are famous for lycopene, a bright red pigment. Imagine lycopene as a giant, stretchy net made of 11 connected double bonds. Its job is to catch a specific type of troublemaker called singlet oxygen and neutralize it before it can hurt the city.

The Cooking Trick: Here's a fun twist: eating raw tomatoes is okay, but cooking them (like making sauce or paste) actually makes the lycopene 2 to 3 times more available for your body to use. It's like heating up the tomato breaks open the walls holding the lycopene, letting it escape and do its job.
The Reality Check: Despite the cool lab results, the paper points out that when scientists tested this on real humans, the results were mixed. A major study of 79 men found that taking lycopene supplements didn't significantly lower a specific marker called PSA (Prostate-Specific Antigen) compared to a fake pill. Another review of 6 studies agreed: lycopene supplements didn't significantly change PSA levels for most people. The paper argues that maybe we need to stop looking at just the supplement and start looking at the whole tomato (the "tomato effect"), because the other ingredients in the fruit might work together better than lycopene alone.

The New Tool: Artificial Intelligence (AI)

This paper is special because it doesn't just look at the food; it uses Artificial Intelligence to figure out how it works. Imagine AI as a super-fast detective that can read millions of books and run millions of simulations in seconds.

The Detective Work: The researchers used AI to simulate how onion and tomato chemicals would interact with cancer proteins. They found that quercetin and lycopene seem to hit multiple targets at once (like a net catching several fish), which is great because cancer is complex.
The Prediction: AI models predicted that these compounds could turn off bad genes (like MYC and BCL2) and turn on good genes (like BAX). In some lab tests, these predictions were spot on, matching real results with a correlation of 0.84.
The Limitation: However, the paper warns that most AI detectives have only been trained on synthetic (man-made) chemicals. They might not be perfect at understanding natural foods yet. The paper suggests we need to teach the AI specifically about natural products so it doesn't get confused.

What This Paper Says (and Doesn't Say)

What is Proven?

Onions and tomatoes contain powerful antioxidants that fight oxidative stress in lab settings.
Onion peels are surprisingly potent.
Cooking tomatoes increases lycopene availability.
Computer simulations show quercetin binds tightly to cancer-related proteins.

What is NOT Proven (and what the paper argues against)?

The "Magic Pill" Myth: The paper explicitly argues against the idea that simply popping a lycopene or quercetin pill will cure prostate cancer or significantly lower PSA levels in everyone. The evidence for supplements is "equivocal" (unclear) and often shows no significant effect.
The "One-Size-Fits-All" Approach: It suggests that taking a single isolated chemical might not work as well as eating the whole food (the "tomato effect") or combining different strategies.

How Sure Are We?

Simulations: The idea that quercetin is a "super-binder" is based on computer models (molecular docking), not confirmed human trials.
Lab Tests: The cell death and gene changes are measured in petri dishes and mice, but these don't always translate perfectly to humans.
Human Trials: The clinical evidence is mixed. Some studies show promise in specific groups, but the big picture says we need better ways to test this.

The Big Picture

This paper is like a map for a treasure hunt. It tells us that onions and tomatoes are likely hiding treasure (cancer-fighting power) in their chemical makeup. It uses AI to show us where the treasure might be buried (specific proteins and pathways).

However, the map also warns us: Don't just grab a single gold coin (a supplement) and expect to win the game. The real treasure might be in the whole meal, the way we cook it, and how we combine it with other treatments. The authors suggest that to truly use this power, we need to:

Fix the "bioavailability" problem (make sure the body actually absorbs the good stuff).
Use AI to find the right patients for the right foods.
Stop throwing away onion skins!

In short, nature has given us powerful tools, but we need to learn how to use them correctly, with the help of smart computers, before we can declare victory over prostate cancer.

Technical Summary: An AI-Informed Review of Onion and Tomato in Prostate Cancer

Problem Statement
Prostate cancer (PCa) remains a leading cause of cancer mortality in men, with current therapies (androgen deprivation, chemotherapy, radiotherapy) frequently limited by castration resistance (CRPC), multidrug resistance, and dose-limiting toxicities. The pathogenesis of PCa is driven significantly by the oxidative stress-inflammatory axis, involving Reactive Oxygen Species (ROS)-induced DNA damage, NF-κB activation, and Androgen Receptor (AR) dysregulation. While dietary phytochemicals from Allium cepa (onion) and Solanum lycopersicum (tomato) show chemopreventive potential, their translation from bench to bedside is hindered by:

Limited systematic characterization of molecular targets and polypharmacological mechanisms.
Suboptimal bioavailability of key compounds like quercetin and lycopene.
Absence of predictive frameworks for prioritizing compounds, leading to equivocal clinical evidence (e.g., meta-analyses showing no significant effect of lycopene on PSA levels).
Under-explored integration of Artificial Intelligence (AI) and machine learning (ML) to deconvolute complex natural product mechanisms.

Methodology
This study employs an Integrative Contemporary Review methodology, synthesizing data from experimental phytochemistry, molecular oncology, and computational biology. The approach is structured around three conceptual pillars:

Oxidative Stress-Inflammation-Cancer Axis: Analyzing the modulation of ROS and inflammatory pathways.
Phytochemical Polypharmacology: Mapping multi-target interactions beyond the "one drug, one target" paradigm.
AI-Enhanced Drug Discovery: Utilizing computational frameworks for screening and prediction.

Data Sources and Criteria:

Search Strategy: Systematic searches were conducted in PubMed, Scopus, Web of Science, IEEE Xplore, and Google Scholar (2004–2025) using Boolean combinations of terms related to PCa, A. cepa, S. lycopersicum, AI, and molecular mechanisms.
Inclusion: Peer-reviewed studies on phytochemical composition, antioxidant/anticancer efficacy (in vitro, in vivo, clinical), and AI/computational applications in PCa. Specific cell lines (LNCaP, PC-3, DU145) and models (TRAMP, xenografts) were prioritized.
Exclusion: Non-peer-reviewed abstracts, non-PCa malignancies (unless comparative), synthetic analogs not derived from onion/tomato precursors, and studies lacking molecular mechanism data.
Quality Assessment: Tools included ToxRTool (in vitro), SYRCLE (in vivo), Cochrane RoB 2 (clinical), and custom checklists for computational studies.

Key Contributions
The paper makes five distinct contributions to the field:

Integrated Phytochemical-Antioxidant Mapping: It synthesizes complementary mechanisms where onion-derived quercetin activates the Nrf2/ARE pathway via Keap1 electrophilic modification, while tomato-derived lycopene quenches singlet oxygen via its conjugated polyene chain. It highlights that processed tomato products offer 2–3 times higher lycopene bioavailability than raw fruit, and onion peel extracts possess 2.3-fold higher antioxidant capacity than flesh.
Mechanistic Deconvolution of Polypharmacology: The review maps specific target landscapes, noting quercetin's preferential activity against metastatic, androgen-independent PCa (via PI3K/Akt and Wnt/β-catenin disruption) versus lycopene's efficacy in androgen-driven proliferation (via 5α-reductase inhibition and AR translocation blockade). It validates the "tomato effect," suggesting whole-food matrices are more effective than isolated supplements due to synergistic interactions.
AI-Methodology Synthesis: It integrates scattered AI applications into a unified translational pipeline, validating tools like AutoDock Vina, STRING/Cytoscape, and Random Forest models. It proposes a framework combining ethnopharmacological mining (via NLP) with computational target prediction.
Gap-Directed Research Agenda: The review identifies critical gaps: the need for bioavailability optimization (nanoformulation), the exploration of combination therapies (quercetin + lycopene + conventional drugs), the shift from PSA to multi-omic biomarkers in clinical trials, and the retraining of AI models to reduce synthetic compound bias.
Methodological Innovation: It rationalizes the "Integrative Contemporary Review" as a necessary methodological evolution for interdisciplinary fields where conceptual synthesis is required over simple evidence aggregation.

Key Results

Molecular Docking & AI Predictions: AI-driven molecular docking identified quercetin as a high-affinity binder of the Androgen Receptor (binding affinity −9.2 kcal/mol), surpassing the reference drug enzalutamide (−8.4 kcal/mol). Network pharmacology identified quercetin, kaempferol, and isorhamnetin as hub compounds enriched in prostate cancer, PI3K-Akt, and apoptosis pathways.
Antioxidant Mechanisms: Quercetin activates Nrf2 by modifying Keap1 cysteine residues, upregulating HO-1 by 3.5-fold. Lycopene's conjugated polyene chain enables efficient singlet oxygen quenching ( $k_q = 3.1 \times 10^{10} M^{-1}s^{-1}$ ).
In Vitro/In Vivo Efficacy: Onion-derived nanovesicles (ODNVs) showed dose-dependent cytotoxicity against PC-3 cells ( $IC_{50}$ 78.4 μg/mL) with selective toxicity. Whole tomato powder reduced tumor size in rat xenografts more effectively than synthetic lycopene beadlets.
Clinical Evidence: Meta-analyses of Randomized Controlled Trials (RCTs) indicate no significant reduction in PSA levels with lycopene supplementation across general populations. However, exploratory subgroup analyses suggest potential benefits in intermediate-risk disease or patients with high baseline PSA.
AI Performance: Machine learning models (Random Forest, SVM) achieved high accuracy ( $R^2 > 0.85$ ) in predicting antioxidant capacity from metabolomic profiles and classifying onion species based on volatile fingerprints. Deep learning models successfully predicted gene expression changes (e.g., downregulation of MYC, BCL2) consistent with experimental qRT-PCR data.

Significance and Claims
The paper claims to offer one of the first comprehensive syntheses linking experimental phytochemistry, molecular oncology, and AI-driven drug discovery specifically for A. cepa and S. lycopersicum in the context of prostate cancer.

Translational Pathway: It proposes a pathway where AI is used not just for screening, but for optimizing bioavailability (via nanoformulation), refining biomarkers (via multi-omics), and developing natural product-specific AI models.
Clinical Relevance: It suggests that dietary intervention strategies and nutraceutical adjuvant therapies could improve treatment outcomes and minimize chemotherapy toxicities, particularly in resource-limited settings.
Future Direction: The review asserts that the future of prostate cancer chemoprevention lies not in single supplements, but in molecularly stratifying patient populations and using AI to formulate synergistic phytochemical combinations within optimal food matrices.

The authors maintain a modest stance regarding clinical claims, acknowledging that while experimental data is robust, clinical evidence remains equivocal, necessitating further validation through precision nutraceutical interventions and advanced biomarker strategies.

The Superheroes: Quercetin and Lycopene

The New Tool: Artificial Intelligence (AI)

What This Paper Says (and Doesn't Say)

The Big Picture

Technical Summary: An AI-Informed Review of Onion and Tomato in Prostate Cancer

More like this